ivWatch Becomes Tech Center Research Park Anchor

Medical device manufacturer welcomed by Newport News innovation hub

NEWPORT NEWS, Va.–(BUSINESS WIRE)–ivWatch,
a medical device manufacturer and biosensor technology company focused
on improving patient safety and the effectiveness of intravenous (IV)
therapy, announced the lease signing as the anchor organization of
Newport News Tech
Center Research Park
’s Building One. The company is relocating from
its Hampton headquarters and Williamsburg research & development (R&D)
facility, combining all departments under one roof.

“The move signifies our ongoing investment in the region and aligns our
strong history of medical innovation with this budding business and
entrepreneurial community,” said Gary Warren, president and CEO of
ivWatch. “The Research Park is the type of space we need to expand our
clinical and R&D efforts, execute manufacturing and national and
international distribution of our product, all while maintaining
essential business functions like operations, sales and marketing.”

As the anchor tenant occupying more than 25,500 sq. ft., the building
will include exterior ivWatch signage. The first-floor manufacturing
space will be housed within sleek glass walls, and state-of-the-art R&D
and office space will be located on the third floor.

The ivWatch move-in is slated to be complete by mid-2019, and a
ribbon-cutting for Building One is planned for August 2019.

To learn more about ivWatch, visit www.ivWatch.com.
To learn more about Tech Center Research Park, visit innovateattechcenterva.com.

About ivWatch:

ivWatch,
LLC
 is a medical biosensor technology company focused on improving
patient safety and the effectiveness of intravenous therapy. Our
dedicated and passionate team is pioneering the use of optical sensors
to detect adverse IV events early to minimize the risk of injury caused
by infiltrations and extravasations. By using this technology,
clinicians are able to leverage continuous monitoring to help identify
infiltrations as early as possible. Our innovative monitored IV
solutions are backed by decades of clinical research and device
development. To learn more, follow us on Twitter @ivWatch or
Facebook @ivWatchLLC,
or visit www.ivwatch.com.

ivWatch is pleased to sponsor the work of myIV.com,
an online resource dedicated to empowering visitors with information on
all things IV, simplified.

Contacts

Amara Betoney
amara.betoney@ivwatch.com
Direct
(757) 224-2606
Office (855) 489-2824 x7007
Mobile (757)
660-4949